Medtronic 2013 Annual Report Download - page 70
Download and view the complete annual report
Please find page 70 of the 2013 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60 -
61 -
62 -
63 -
64 -
65 -
66 -
67 -
68 -
69 -
70 -
71 -
72 -
73 -
74 -
75 -
76 -
77 -
78 -
79 -
80 -
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
 |
 |
75732me_10K.indd 55 6/25/13 6:39 PM
Table of Contents
presence in new markets, including markets outside the U.S.; changes in the market and our market share; acquisitions and
investment initiatives, as well as integration of acquired companies into our operations; the resolution of tax matters; the
effectiveness of our development activities in reducing patient care costs and hospital stay lengths; our approach towards cost
containment; our expectations regarding health care costs; the elimination of certain positions or costs related to restructuring
initiatives; outcomes in our litigation matters and government investigations; general economic conditions; the adequacy of
available working capital and our working capital needs; the continued strength of our balance sheet and liquidity; our accounts
receivable exposure; and the potential impact of our compliance with governmental regulations and accounting guidance. One
must carefully consider forward-looking statements and understand that such statements may be affected by inaccurate assumptions
and may involve a variety of risks and uncertainties, known and unknown, including, among others, those discussed in the sections
entitled “Government Regulation and Other Considerations” within “Item 1. Business” and “Item 1A. Risk Factors” in this Annual
Report on Form 10-K, as well as those related to competition in the medical device industry, reduction or interruption in our supply,
quality problems, liquidity, decreasing prices, adverse regulatory action, litigation results, self-insurance, commercial insurance,
health care policy changes, and international operations. Consequently, no forward-looking statement can be guaranteed and actual
results may vary materially. We intend to take advantage of the Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995 regarding our forward-looking statements, and are including this sentence for the express purpose of enabling us to
use the protections of the safe harbor with respect to all forward-looking statements.
We undertake no obligation to update any statement we make, but investors are advised to consult all other disclosures by us in
our filings with the Securities and Exchange Commission, especially on Forms 10-K, 10-Q, and 8-K, in which we discuss in more
detail various important factors that could cause actual results to differ from expected or historical results. In addition, actual
results may differ materially from those anticipated due to a number of factors, including, among others, those discussed in the
section entitled “Item 1A. Risk Factors” in this Annual Report on Form 10-K. It is not possible to foresee or identify all such
factors. As such, investors should not consider any list of such factors to be an exhaustive statement of all risks, uncertainties, or
potentially inaccurate assumptions.
52